The Department of Defense awards contracts to Anthropic, Google, OpenAI, and xAI to accelerate adoption of advanced AI capabilities, leveraging frontier companies' technology and talent to develop agentic AI workflows across mission areas through a commercial-first approach.
AI powerhouses Anthropic, Google, OpenAI, and Elon Musk's xAI secure lucrative defense contracts worth up to $200 million from the U.S. government, signaling the military's accelerated adoption of cutting-edge AI capabilities for national security, while Musk unveils Grok for Government, an AI suite tailored for government agencies.
Former President Trump wields sweeping veto power over major decisions at U.S. Steel, including plant closures and wage cuts, through a 'golden share' that transfers to government agencies after his presidency.
An AI arms race with China dominates the congressional agenda as state-level AI regulations loom, fueling debates on preempting a patchwork of laws while weighing AI's public benefits and risks.
Police in Prince George's County, Maryland, credit stop sign cameras for a drastic drop in violations, with some towns seeing a 38-50% decrease, prompting lawmakers to consider expanding the pilot program to Montgomery County to improve pedestrian safety and reduce accidents.
Elon Musk and multiple senior officials are departing Trump's Department of Government Efficiency (DOGE) as their 130-day tenures as special government employees expire, signaling potential shifts in the administration's aggressive cost-cutting efforts that have sparked legal battles.
Elon Musk's brief but tumultuous stint in the Trump Administration as head of the cost-cutting DOGE agency ended, leaving behind a controversial legacy of sweeping cuts and layoffs amidst unmet savings goals, legal challenges, and clashes with officials.
Taiwan Semiconductor Manufacturing Co. (TSMC) requests tariff exemptions from the Trump administration, cautioning that import duties could inflate costs and derail its U.S. chip production initiatives, including its newly-commenced Arizona factory.
In a groundbreaking move, the FDA has announced an aggressive timeline to integrate AI across all centers by June 30, 2025, following a successful pilot that significantly reduced scientific review times from days to minutes, promising to accelerate the approval process for new therapies.
The U.S. House approved a contentious 10-year AI regulation freeze, drawing criticism for hindering state consumer protections, but the measure faces an uphill battle in the Senate due to procedural hurdles.